ResearcherPhramongkutklao HospitalActive in the last 2 years

Tawasapon Thambamroong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6066-4253; OpenAlex author ID A5031770724. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicen… Co-author DOI 10.1136/bmjonc-2026-001085 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Krittiya Korphaisarn · 1 shared paper, 2026 · strength 0.23
- Paper Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanc… DOI 10.1136/bmjonc-2026-001085 ↗
Ekaphop Sirachainan · 1 shared paper, 2026 · strength 0.23
- Paper Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanc… DOI 10.1136/bmjonc-2026-001085 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.